Healthy high growth potential

Results

1471

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1471 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
FWRY
ج.م18.40-3.2%50.8%ج.م62.7bج.م22.4523.627.3%n/aDiversified Financials
AXSM
US$240.661.2%131.6%US$12.6bUS$276.4717.557.4%n/aPharmaceuticals & Biotech
MDGL
US$514.390.9%71.4%US$12.4bUS$678.7110.559.2%n/aPharmaceuticals & Biotech
MOD
US$244.49-11.6%139.2%US$14.1bUS$340.86106.349.3%n/aCapital Goods
CRDO
US$259.09-3.7%189.9%US$50.7bUS$269.81102.327.5%n/aSemiconductors
CORT
US$88.488.5%24.0%US$9.3bUS$88.00203.548.9%n/aPharmaceuticals & Biotech
NVDA
US$197.58-0.7%25.6%US$4.8tUS$301.6230.022.2%0.5%Semiconductors
LITE
US$801.16-4.9%778.1%US$66.8bUS$1,111.29142.079.1%n/aTech
688072
CN¥832.001.1%456.3%CN¥234.1bCN¥511.08142.435.2%0.04%Semiconductors
4417
JP¥4,030.0022.1%34.8%JP¥60.6bJP¥4,500.0040.824.1%0.8%Software
325
HK$44.608.3%-67.5%HK$11.1bHK$81.0015.122.7%n/aConsumer Durables
002810
CN¥25.270.4%88.0%CN¥8.7bCN¥36.0043.843.1%1.6%Materials
MX1
AU$0.0356.1%-22.2%AU$26.2mAU$0.151.5105.5%n/aHealthcare
1729
HK$14.70-25.1%88.0%HK$32.8bHK$25.0041.933.6%0.3%Capital Goods
2480
HK$12.74-0.5%-47.1%HK$2.5bHK$31.003.377.1%n/aPharmaceuticals & Biotech
SKS
AU$8.74-4.9%356.4%AU$1.0bAU$8.9058.942.4%0.7%Capital Goods
PNI
AU$17.855.4%-13.0%AU$4.2bAU$22.1333.321.1%3.1%Diversified Financials
9218
JP¥733.003.8%12.8%JP¥7.7bn/a32.428.9%1.4%Healthcare
002970
CN¥53.71-10.6%9.4%CN¥9.8bn/a30.036.5%1.9%Automobiles
2315
HK$46.6012.3%97.5%HK$49.4bHK$62.0262.140.4%n/aPharmaceuticals & Biotech
SAATVIKGL
₹453.65-4.6%n/a₹57.7b₹520.0016.148.8%n/aSemiconductors
NORTHERN
RM 0.676.3%2.3%RM 265.1mRM 1.0017.339.5%n/aCapital Goods
300432
CN¥19.63-7.7%50.9%CN¥33.6bCN¥34.4066.360.7%0.5%Automobiles
688192
CN¥43.6311.7%-32.4%CN¥20.3bCN¥83.0022.7105.9%n/aPharmaceuticals & Biotech
Page 1 of 41